Open AccessPB1922: EFFECTIVENESS OF AZACITIDINE IN FRONTLINE HIGHER‐RISK MYELODYSPLASTIC SYNDROME (HR MDS): A RETROSPECTIVE COHORT STUDY OF 382 PATIENTS
Author(s) -
Rajakumaraswamy N.,
Gandhi M.,
Wei A. H.,
Sallman D. A.,
Daver N. G.,
Mo S.,
Iqbal S.,
Chen M.,
Wang Y.,
Vyas P.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850540.71502.0d
Subject(s) - medicine , azacitidine , international prognostic scoring system , cohort , retrospective cohort study , myelodysplastic syndromes , population , oncology , pediatrics , environmental health , bone marrow , biochemistry , gene expression , chemistry , dna methylation , gene